HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteopontin-Rac1 on Blood-Brain Barrier Stability Following Rodent Neonatal Hypoxia-Ischemia.

Abstract
Osteopontin (OPN) is a neuroprotective molecule that is upregulated following rodent neonatal hypoxic-ischemic (nHI) brain injury. Because Rac1 is a regulator of blood-brain barrier (BBB) stability, we hypothesized a role for this in OPN signaling. nHI was induced by unilateral ligation of the right carotid artery followed by hypoxia (8 % oxygen for 2 h) in P10 Sprague-Dawley rat pups. Intranasal (iN) OPN was administered at 1 h post-nHI. Groups consisted of: (1) Sham, (2) Vehicle, (3) OPN, and (4) OPN + Rac1 inhibitor (NSC23766). Evans blue dye extravasation (BBB permeability) was quantified 24 h post-nHI, and brain edema at 48 h. Increased BBB permeability and brain edema following nHI was ameliorated in the OPN treatment group. However, those rat pups receiving OPN co-treatment with the Rac1 inhibitor experienced no improvement compared with vehicle. OPN protects the BBB following nHI, and this was reversed by Rac1 inhibitor (NSC23766).
AuthorsBrandon Dixon, Jay Malaguit, Darlene Casel, Desislava Doycheva, Jiping Tang, John H Zhang, Tim Lekic
JournalActa neurochirurgica. Supplement (Acta Neurochir Suppl) Vol. 121 Pg. 263-7 ( 2016) ISSN: 0065-1419 [Print] Austria
PMID26463959 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Aminoquinolines
  • NSC 23766
  • Neuroprotective Agents
  • Pyrimidines
  • Osteopontin
  • rac1 GTP-Binding Protein
Topics
  • Aminoquinolines (pharmacology)
  • Animals
  • Animals, Newborn
  • Blood-Brain Barrier (drug effects, metabolism)
  • Brain Edema (metabolism)
  • Carotid Arteries (surgery)
  • Hypoxia-Ischemia, Brain (metabolism)
  • Ligation
  • Neuroprotective Agents (pharmacology)
  • Osteopontin (pharmacology)
  • Permeability
  • Pyrimidines (pharmacology)
  • Rats, Sprague-Dawley
  • rac1 GTP-Binding Protein (antagonists & inhibitors, drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: